JNK inhibition reduces lung remodeling and pulmonary fibrotic systemic markers

BACKGROUND: Lung remodeling and pulmonary fibrosis are serious, life-threatening conditions resulting from diseases such as chronic severe asthma and idiopathic pulmonary fibrosis (IPF). Preclinical evidence suggests that JNK enzyme function is required for key steps in the pulmonary fibrotic proces...

Descripción completa

Detalles Bibliográficos
Autores principales: van der Velden, Jos L. J., Ye, Ying, Nolin, James D., Hoffman, Sidra M., Chapman, David G., Lahue, Karolyn G., Abdalla, Sarah, Chen, Peng, Liu, Yong, Bennett, Brydon, Khalil, Nasreen, Sutherland, Donna, Smith, William, Horan, Gerald, Assaf, Mahmoud, Horowitz, Zebulun, Chopra, Rajesh, Stevens, Randall M., Palmisano, Maria, Janssen-Heininger, Yvonne M. W., Schafer, Peter H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5010551/
https://www.ncbi.nlm.nih.gov/pubmed/27590145
http://dx.doi.org/10.1186/s40169-016-0117-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5010551/
https://www.ncbi.nlm.nih.gov/pubmed/27590145
http://dx.doi.org/10.1186/s40169-016-0117-2

Ejemplares similares